CollPlant Biotechnologies (CLGN) Competitors $3.75 +0.07 (+1.90%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends CLGN vs. BWAY, DRTS, PDEX, GUTS, LAKE, KRMD, TLSI, EDAP, SRTS, and FONRShould you be buying CollPlant Biotechnologies stock or one of its competitors? The main competitors of CollPlant Biotechnologies include BrainsWay (BWAY), Alpha Tau Medical (DRTS), Pro-Dex (PDEX), Fractyl Health (GUTS), Lakeland Industries (LAKE), KORU Medical Systems (KRMD), TriSalus Life Sciences (TLSI), Edap Tms (EDAP), Sensus Healthcare (SRTS), and FONAR (FONR). These companies are all part of the "medical equipment" industry. CollPlant Biotechnologies vs. BrainsWay Alpha Tau Medical Pro-Dex Fractyl Health Lakeland Industries KORU Medical Systems TriSalus Life Sciences Edap Tms Sensus Healthcare FONAR CollPlant Biotechnologies (NASDAQ:CLGN) and BrainsWay (NASDAQ:BWAY) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation, media sentiment, analyst recommendations and community ranking. Is CLGN or BWAY more profitable? BrainsWay has a net margin of 1.67% compared to CollPlant Biotechnologies' net margin of -2,535.70%. BrainsWay's return on equity of 1.45% beat CollPlant Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets CollPlant Biotechnologies-2,535.70% -65.98% -54.37% BrainsWay 1.67%1.45%0.96% Do analysts rate CLGN or BWAY? CollPlant Biotechnologies currently has a consensus target price of $11.00, suggesting a potential upside of 193.33%. BrainsWay has a consensus target price of $13.17, suggesting a potential upside of 28.71%. Given CollPlant Biotechnologies' stronger consensus rating and higher possible upside, research analysts plainly believe CollPlant Biotechnologies is more favorable than BrainsWay.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CollPlant Biotechnologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50BrainsWay 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Do insiders & institutionals believe in CLGN or BWAY? 21.7% of CollPlant Biotechnologies shares are held by institutional investors. Comparatively, 30.1% of BrainsWay shares are held by institutional investors. 9.6% of CollPlant Biotechnologies shares are held by company insiders. Comparatively, 19.0% of BrainsWay shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has better earnings & valuation, CLGN or BWAY? BrainsWay has higher revenue and earnings than CollPlant Biotechnologies. CollPlant Biotechnologies is trading at a lower price-to-earnings ratio than BrainsWay, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCollPlant Biotechnologies$689K62.35-$7.02M-$1.54-2.44BrainsWay$36.43M4.68-$4.20M$0.05204.60 Does the media favor CLGN or BWAY? In the previous week, BrainsWay had 2 more articles in the media than CollPlant Biotechnologies. MarketBeat recorded 2 mentions for BrainsWay and 0 mentions for CollPlant Biotechnologies. BrainsWay's average media sentiment score of 0.98 beat CollPlant Biotechnologies' score of 0.00 indicating that BrainsWay is being referred to more favorably in the news media. Company Overall Sentiment CollPlant Biotechnologies Neutral BrainsWay Positive Does the MarketBeat Community believe in CLGN or BWAY? CollPlant Biotechnologies received 68 more outperform votes than BrainsWay when rated by MarketBeat users. However, 66.67% of users gave BrainsWay an outperform vote while only 59.13% of users gave CollPlant Biotechnologies an outperform vote. CompanyUnderperformOutperformCollPlant BiotechnologiesOutperform Votes13659.13% Underperform Votes9440.87% BrainsWayOutperform Votes6866.67% Underperform Votes3433.33% Which has more risk & volatility, CLGN or BWAY? CollPlant Biotechnologies has a beta of 0.31, meaning that its share price is 69% less volatile than the S&P 500. Comparatively, BrainsWay has a beta of 1.26, meaning that its share price is 26% more volatile than the S&P 500. SummaryBrainsWay beats CollPlant Biotechnologies on 14 of the 19 factors compared between the two stocks. Ad Timothy SykesTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025.Click here to see the surprising reason why Get CollPlant Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for CLGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLGN vs. The Competition Export to ExcelMetricCollPlant BiotechnologiesSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$42.18M$9.80B$5.54B$8.53BDividend YieldN/A1.09%5.13%4.14%P/E Ratio-2.4421.39114.8115.14Price / Sales62.3540.471,495.55100.10Price / CashN/A25.5539.6734.08Price / Book1.525.774.665.02Net Income-$7.02M$181.29M$119.06M$225.46M7 Day Performance-5.60%-3.12%0.80%0.37%1 Month Performance-20.72%-7.16%5.65%3.57%1 Year Performance-32.55%2.34%36.75%29.43% CollPlant Biotechnologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLGNCollPlant Biotechnologies1.9874 of 5 stars$3.75+1.9%$11.00+193.3%-43.5%$42.18M$689,000.00-2.4470BWAYBrainsWay3.0354 of 5 stars$10.00+0.5%$13.17+31.7%+180.3%$166.80M$31.78M200.04120Gap UpDRTSAlpha Tau Medical2.151 of 5 stars$2.34+5.4%$8.00+241.9%-32.7%$163.03MN/A-5.8580Gap UpPDEXPro-Dex1.6513 of 5 stars$45.29+46.0%$30.00-33.8%+108.7%$150.50M$53.84M73.05140News CoverageGap UpHigh Trading VolumeGUTSFractyl Health1.6187 of 5 stars$2.99+6.0%$22.00+635.8%N/A$143.31M$120,000.000.00102Gap UpLAKELakeland Industries4.8669 of 5 stars$18.39-1.1%$26.50+44.1%+34.7%$136.09M$124.69M76.631,750Analyst DowngradeNews CoverageKRMDKORU Medical Systems1.3942 of 5 stars$2.92+11.0%$3.33+14.2%+20.5%$133.88M$28.52M-11.6880Short Interest ↑TLSITriSalus Life Sciences3.5289 of 5 stars$3.97-0.3%$12.50+214.9%-8.2%$116.36M$18.51M-1.59106News CoverageGap DownHigh Trading VolumeEDAPEdap Tms2.1099 of 5 stars$2.97+2.4%$14.00+371.4%-57.7%$110.19M$65.42M-5.12307Upcoming EarningsSRTSSensus Healthcare3.2267 of 5 stars$6.45+0.8%$10.00+55.0%+209.9%$105.72M$24.41M15.7340Positive NewsFONRFONAR1.2954 of 5 stars$15.20-1.9%N/A+14.1%$96.22M$102.88M9.93480Analyst Downgrade Related Companies and Tools Related Companies BrainsWay Competitors Alpha Tau Medical Competitors Pro-Dex Competitors Fractyl Health Competitors Lakeland Industries Competitors KORU Medical Systems Competitors TriSalus Life Sciences Competitors Edap Tms Competitors Sensus Healthcare Competitors FONAR Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CLGN) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CollPlant Biotechnologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share CollPlant Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CLGN Stock Alerts